Jaume M - Search Results

1

Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway.

Jaume M, Yip MS, Cheung CY, Leung HL, Li PH, Kien F, Dutry I, Callendret B, Escriou N, Altmeyer R, Nal B, Daëron M, Bruzzone R, Peiris JS. Jaume M, et al. J Virol. 2011 Oct;85(20):10582-97. doi: 10.1128/JVI.00671-11. Epub 2011 Jul 20. J Virol. 2011. PMID: 21775467 Free PMC article.

2

SARS CoV subunit vaccine: antibody-mediated neutralisation and enhancement.

Jaume M, Yip MS, Kam YW, Cheung CY, Kien F, Roberts A, Li PH, Dutry I, Escriou N, Daeron M, Bruzzone R, Subbarao K, Peiris JS, Nal B, Altmeyer R. Jaume M, et al. Hong Kong Med J. 2012 Feb;18 Suppl 2:31-6. Hong Kong Med J. 2012. PMID: 22311359 Free article.

3

Ezrin interacts with the SARS coronavirus Spike protein and restrains infection at the entry stage.

Millet JK, Kien F, Cheung CY, Siu YL, Chan WL, Li H, Leung HL, Jaume M, Bruzzone R, Peiris JS, Altmeyer RM, Nal B. Millet JK, et al. Among authors: jaume m. PLoS One. 2012;7(11):e49566. doi: 10.1371/journal.pone.0049566. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185364 Free PMC article.

4

Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus.

Yip MS, Leung NH, Cheung CY, Li PH, Lee HH, Daëron M, Peiris JS, Bruzzone R, Jaume M. Yip MS, et al. Among authors: jaume m. Virol J. 2014 May 6;11:82. doi: 10.1186/1743-422X-11-82. Virol J. 2014. PMID: 24885320 Free PMC article.

5

Antibody-dependent enhancement of SARS coronavirus infection and its role in the pathogenesis of SARS.

Yip MS, Leung HL, Li PH, Cheung CY, Dutry I, Li D, Daëron M, Bruzzone R, Peiris JS, Jaume M. Yip MS, et al. Among authors: jaume m. Hong Kong Med J. 2016 Jun;22(3 Suppl 4):25-31. Hong Kong Med J. 2016. PMID: 27390007 Free article. No abstract available.

6

Toll-like receptor 10 is involved in induction of innate immune responses to influenza virus infection.

Lee SM, Kok KH, Jaume M, Cheung TK, Yip TF, Lai JC, Guan Y, Webster RG, Jin DY, Peiris JS. Lee SM, et al. Among authors: jaume m. Proc Natl Acad Sci U S A. 2014 Mar 11;111(10):3793-8. doi: 10.1073/pnas.1324266111. Epub 2014 Feb 24. Proc Natl Acad Sci U S A. 2014. PMID: 24567377 Free PMC article.

7

Role of PATJ in stroke prognosis by modulating endothelial to mesenchymal transition through the Hippo/Notch/PI3K axis.

Medina-Dols A, Cañellas G, Capó T, Solé M, Mola-Caminal M, Cullell N, Jaume M, Nadal-Salas L, Llinàs J, Gómez L, Tur S, Jiménez C, Díaz RM, Carrera C, Muiño E, Gallego-Fabrega C, Soriano-Tárraga C, Ruiz-Guerra L, Pol-Fuster J, Asensio V, Muncunill J, Fleischer A, Iglesias A, Giralt-Steinhauer E, Lazcano U, Fernández-Pérez I, Jiménez-Balado J, Gabriel-Salazar M, Garcia-Gabilondo M, Lei T, Torres-Aguila NP, Cárcel-Márquez J, Lladó J, Olmos G, Rosell A, Montaner J, Planas AM, Rabionet R, Hernández-Guillamon M, Jiménez-Conde J, Fernández-Cadenas I, Vives-Bauzá C. Medina-Dols A, et al. Among authors: jaume m. Cell Death Discov. 2024 Feb 17;10(1):85. doi: 10.1038/s41420-024-01857-z. Cell Death Discov. 2024. PMID: 38368420 Free PMC article.

8

Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project.

Bruguera A, Egea-Cortés L, Mesías-Gazmuri J, Palacio-Vieira J, Forero CG, Miranda C, Saumoy M, Fernández E, Navarro G, Orti A, Miró JM, Casabona J, Reyes-Urueña J; PISCS Study Group. Bruguera A, et al. HIV Med. 2024 Apr;25(4):424-439. doi: 10.1111/hiv.13590. Epub 2023 Dec 13. HIV Med. 2024. PMID: 38092529

9

Cohort Profile: PISCIS, a population-based cohort of people living with HIV in Catalonia and Balearic Islands.

Bruguera A, Nomah D, Moreno-Fornés S, Díaz Y, Aceitón J, Reyes-Urueña J, Ambrosioni J, Llibre JM, Falcó V, Imaz A, Fanjul F, Navarro G, Pere D, León E, Mera A, Miró JM, Casabona J; PISCIS Cohort Group. Bruguera A, et al. Int J Epidemiol. 2023 Aug 2;52(4):e241-e252. doi: 10.1093/ije/dyad083. Int J Epidemiol. 2023. PMID: 37403345 No abstract available.

10

Mortality and immunovirological outcomes in patients with advanced HIV disease on their first antiretroviral treatment: differential impact of antiretroviral regimens.

Burgos J, Moreno-Fornés S, Reyes-Urueña J, Bruguera A, Martín-Iguacel R, Raventos B, Llibre JM, Imaz A, Peraire J, Orti AJ, Dalmau D, Casabona J, Miró JM, Falcó V; PISCIS study group. Burgos J, et al. J Antimicrob Chemother. 2022 Dec 23;78(1):108-116. doi: 10.1093/jac/dkac361. J Antimicrob Chemother. 2022. PMID: 36308326

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page